You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Percutaneous coronary intervention (PCI), oral anticoagulants, atrial fibrillation, DOAC.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • Coronary Artery Disease
  • (no location specified)
Oct 22, 2023

Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)

Active, not recruiting
  • Atrial Fibrillation
  • Acute Coronary Syndrome
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Jan 12, 2023

Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,

Not yet recruiting
  • Percutaneous Coronary Intervention (PCI)
  • +3 more
  • P2Y12 inhibitor
  • +2 more
  • Hasselt, Belgium
  • +13 more
Jul 25, 2023

Atrial Fibrillation, Coronary Artery Disease, Anticoagulants Trial (Uninterrupted NOAC use, Interrupted NOAC use)

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Uninterrupted NOAC use
  • Interrupted NOAC use
  • (no location specified)
Jul 20, 2021

Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Xi'an (The WATCHMAN/WATCHMAN FLX device, Rivaroxaban +

Not yet recruiting
  • Atrial Fibrillation
  • Percutaneous Coronary Intervention
  • The WATCHMAN/WATCHMAN FLX device
  • +2 more
  • Xi'an, Shannxi, China
    Ling Tao
Jul 20, 2022

Rivaroxaban - Percutaneous Coronary Intervention

Completed
  • Coronary Artery Disease
  • Atrial Fibrillation
  • In vitro heparin
  • Bursa, Turkey
    Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Sep 13, 2022

Atrial Fibrillation, Stroke Trial in Edmonton (Anticoagulants)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 8, 2022

Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI

Completed
  • Non-valvular Atrial Fibrillation
  • +3 more
    • Bad Nauheim, Germany
    • +12 more
    Mar 30, 2022

    Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome Trial in Gdansk (Ticagrelor, Dabigatran Etexilate, Aspirin)

    Recruiting
    • Atrial Fibrillation
    • +3 more
    • Gdańsk, Pomorskie, Poland
      Cardiac lntensive Care Unit, First Department of Cardiology, Uni
    Oct 27, 2021

    Subject Under Anticoagulant Trial in Marseille (an observational study)

    Recruiting
    • Subject Under Anticoagulant
    • an observational study
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Aug 12, 2022

    Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

    Not yet recruiting
    • Coronary Artery Disease
    • +2 more
    • Aspirin + Clopidogrel + Rivaroxaban
    • Aspirin + Clopidogrel
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences, Fuwai Hospital
    Dec 5, 2022

    Atrial Fibrillation, Stroke Trial in United States (Early Patient-Level and Provider-Level Educational Intervention, Delayed

    Active, not recruiting
    • Atrial Fibrillation
    • Stroke
    • Early Patient-Level and Provider-Level Educational Intervention
    • Delayed Provider-Level Educational Intervention
    • Louisville, Kentucky
    • +3 more
    Dec 4, 2021

    Atrial Fibrillation, Coronary Artery Disease Trial in Athens (VKA, NOAC)

    Completed
    • Atrial Fibrillation
    • Coronary Artery Disease
    • Athens, Attika, Greece
      Attikon University Hospital
    Jul 23, 2021

    Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation Trial (First month DAPT, First month standard therapy)

    Not yet recruiting
    • Acute Coronary Syndrome
    • +10 more
    • First month DAPT
    • First month standard therapy
    • (no location specified)
    Apr 16, 2021

    Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)

    Recruiting
    • Coronary Artery Disease
    • Jacksonville, Florida
      University of Florida
    Jul 6, 2022

    Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

    Recruiting
    • Bleeding Post Cardiac Surgery
    • Indication for Anticoagulation
    • Hamilton, Ontario, Canada
      Hamilton General Hospital
    Oct 31, 2022

    Ischemic Stroke, Atrial Fibrillation Trial (Left atrial appendage Occlusion and 3 months of Clopidogrel, DOAC)

    Not yet recruiting
    • Ischemic Stroke
    • Atrial Fibrillation
    • Left atrial appendage Occlusion and 3 months of Clopidogrel
    • DOAC
    • (no location specified)
    Jul 27, 2023

    Interference Between Oral Anticoagulants and Heparin During

    Recruiting
    • Atrial Fibrillation
    • Atrial Tachycardia
      • Paris, France
        Hopital Bichat-Claude Bernard
      Mar 27, 2023

      Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral

      Recruiting
      • Coronary Artery Disease
      • +2 more
      • Direct-acting oral anticoagulation
      • Rozzano, Milan, Italy
      • +3 more
      Mar 22, 2022

      DOAC in Chinese Patients With Atrial Fibrillation

      Recruiting
      • Atrial Fibrillation
      • +6 more
      • Blood Tests
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      Oct 11, 2022

      Radial Artery Occlusion Trial in Kingston, Ottawa (Rivaroxaban 15 MG Oral Tablet [Xarelto])

      Recruiting
      • Radial Artery Occlusion
      • Rivaroxaban 15 MG Oral Tablet [Xarelto]
      • Kingston, Ontario, Canada
      • +1 more
      Feb 8, 2022

      Atrial Fibrillation Trial in United States (AFSW Guided DOAC, Continuous DOAC therapy)

      Not yet recruiting
      • Atrial Fibrillation
      • AFSW Guided DOAC
      • Continuous DOAC therapy
      • (no location specified)
      Apr 19, 2023

      Elaboration ofPrioritization Score for Pharmaceutical Interviews

      Completed
      • Thromboembolic Event
      • Survey
      • Reims, France
        Chu Reims
      Oct 19, 2023

      Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)

      Recruiting
      • Atrial Fibrillation
      • Recurrent Venous Thromboembolism
      • dabigatran, rivaroxaban, apixaban or edoxaban
      • Barcelona, Catalonia, Spain
        Hospital de la Santa Creu i Sant Pau
      Apr 27, 2022

      Oral Anti-coagulants in Fragile Percutaneous Endoscopic

      Completed
      • Atrial Fibrillation
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Oct 25, 2021